22 octubre 2009

Yondelis , La FDA ha negado a las Mujeres de EEUU una nueva opción potencialmente poderosa para la lucha contra el Cáncer de Ovarios.

Thursday, Oct. 22, 2009
Just in case: Items suggesting the direction of things
By ROSS MACKENZIE .

...

- According to the executive director of the Sarcoma Foundation, the federal Food and Drug Administration has "turned its back on 25 years of regulatory precedent and rejected a new cancer drug that by all known standards had passed muster for approval." Rejection of the chemotherapy drug, Yondelis, thus denies women a potentially powerful new option for fighting ovarian cancer.

...